Back to Search
DAVID VANDERWEELE, M.D.
M.D.
Medical Oncology Physician
NPI: 1689846834IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
036123890(IL)
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2007
Research & Publications (7)
Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate.
PMID 16317089·Mol Cancer Res·2005
7-preclinical
Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin.
PMID 15634654·Mol Cancer Ther·2004
7-preclinical
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
PMID 18978206·Blood·2009
8-other
Svf1 inhibits reactive oxygen species generation and promotes survival under conditions of oxidative stress in Saccharomyces cerevisiae.
PMID 16034825·Yeast·2005
7-preclinical
No relationship between sequence variation in protein coding regions of the Tas1r3 gene and saccharin preference in rats.
PMID 15741599·Chem Senses·2005
7-preclinical
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
PMID 12543781·Cancer Res·2003
8-other
Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism.
PMID 12244097·J Biol Chem·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 10 Center Dr
Bethesda, MD 20892 - Phone
- (301) 319-2919
Quick Facts
- NPI
- 1689846834
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 19
- Publications
- 7
Are you this provider?
Claim Your Profile